ABSTRACT
Caesarean section scar diverticulum (CSD) is a significant cause of infertility among women who have previously had a Caesarean section, primarily due to persistent inflammatory exudation associated with this condition. Even though abnormal bacterial composition is identified as a critical factor leading to this chronic inflammation, clinical data suggest that a long-term cure is often unattainable with antibiotic treatment alone. In our study, we employed metagenomic analysis and mass spectrometry techniques to investigate the fungal composition in CSD and its interaction with bacteria. We discovered that local fungal abnormalities in CSD can disrupt the stability of the bacterial population and the entire microbial community by altering bacterial abundance via specific metabolites. For instance, Lachnellula suecica reduces the abundance of several Lactobacillus spp., such as Lactobacillus jensenii, by diminishing the production of metabolites like Goyaglycoside A and Janthitrem E. Concurrently, Clavispora lusitaniae and Ophiocordyceps australis can synergistically impact the abundance of Lactobacillus spp. by modulating metabolite abundance. Our findings underscore that abnormal fungal composition and activity are key drivers of local bacterial dysbiosis in CSD.
Subject(s)
Bacteria , Cesarean Section , Cicatrix , Diverticulum , Female , Cesarean Section/adverse effects , Humans , Diverticulum/microbiology , Diverticulum/metabolism , Bacteria/metabolism , Bacteria/genetics , Cicatrix/microbiology , Cicatrix/metabolism , Dysbiosis/microbiology , Fungi/metabolism , Fungi/genetics , Fungi/physiology , Microbial Interactions , MicrobiotaABSTRACT
INTRODUCTION: The etiology of diverticulosis is still poorly understood. However, in patients with diverticulitis, markers of mucosal inflammation and microbiota alterations have been found. The aim of this study was to evaluate potential differences of the gut microbiota composition and mucosal immunity between patients with asymptomatic diverticulosis and controls. METHODS: We performed a prospective study on patients who underwent routine colonoscopy for causes not related to diverticular disease or inflammatory bowel disease. Participants were grouped based on the presence or absence of diverticula. Mucosal biopsies were obtained from the sigmoid and transverse colon. Microbiota composition was analyzed with IS-pro, a 16S-23S based bacterial profiling technique. To predict if patients belonged to the asymptomatic diverticulosis or control group a partial least squares discriminant analysis (PLS-DA) regression model was used. Inflammation was assessed by neutrophil and lymphocyte counts within the taken biopsies. RESULTS: Forty-three patients were enrolled. Intestinal microbiota profiles were highly similar within individuals for all phyla. Between individuals, microbiota profiles differed substantially but regardless of the presence (n = 19) of absence (n = 24) of diverticula. Microbiota diversity in both sigmoid and transverse colon was similar in all participants. We were not able to differentiate between diverticulosis patients and controls with a PLS-DA model. Mucosal lymphocyte counts were comparable among both groups; no neutrophils were detected in any of the studied biopsies. CONCLUSIONS: Microbiota composition and inflammatory markers were comparable among asymptomatic diverticulosis patients and controls. This suggests that the gut microbiota and mucosal inflammation do not play a major role in the pathogenesis of diverticula formation.
Subject(s)
Asymptomatic Diseases/epidemiology , Diverticulum/immunology , Diverticulum/microbiology , Inflammation/microbiology , Aged , Colon, Sigmoid/microbiology , Colon, Sigmoid/pathology , Colonoscopy , Diverticulum/epidemiology , Diverticulum/genetics , Female , Gastrointestinal Microbiome/genetics , Humans , Immunity, Mucosal/genetics , Immunity, Mucosal/immunology , Inflammation/epidemiology , Inflammation/pathology , Male , Middle Aged , RNA, Ribosomal, 16S/genetics , RNA, Ribosomal, 16S/immunologyABSTRACT
Gut microbiota composition and functionality are involved in the pathophysiology of several intestinal and extraintestinal diseases, and are increasingly considered a modulator of local and systemic inflammation. However, the involvement of gut microbiota in diverticulosis and in diverticular disease is still poorly investigated. In this review, we critically analyze the existing evidence on the fecal and mucosa-associated microbiota composition and functionality across different stages of diverticular disease. We also explore the influence of risk factors for diverticulosis on gut microbiota composition, and speculate on the possible relevance of these associations for the pathogenesis of diverticula. We overview the current treatments of diverticular disease targeting the intestinal microbiome, highlighting the current areas of uncertainty and the need for future studies. Although no conclusive remarks on the relationship between microbiota and diverticular disease can be made, preliminary data suggest that abdominal symptoms are associated with reduced representation of taxa with a possible anti-inflammatory effect, such as Clostridium cluster IV, and overgrowth of Enterobacteriaceae, Bifidobacteria and Akkermansia. The role of the microbiota in the early stages of the disease is still very uncertain. Future studies should help to disentangle the role of the microbiome in the pathogenesis of diverticular disease and its progression towards more severe forms.
Subject(s)
Bacteria/growth & development , Diverticulitis/microbiology , Diverticulum/microbiology , Gastrointestinal Microbiome , Intestinal Mucosa/microbiology , Animals , Bacteria/genetics , Diverticulitis/epidemiology , Diverticulitis/therapy , Diverticulum/epidemiology , Diverticulum/therapy , Dysbiosis , Feces/microbiology , Host-Pathogen Interactions , Humans , Risk FactorsSubject(s)
Blind Loop Syndrome/diagnostic imaging , Blind Loop Syndrome/drug therapy , Diverticulum/diagnostic imaging , Diverticulum/microbiology , Jejunal Diseases/diagnostic imaging , Jejunal Diseases/microbiology , Anti-Bacterial Agents/therapeutic use , Balloon Enteroscopy , Blind Loop Syndrome/microbiology , Diverticulum/drug therapy , Follow-Up Studies , Humans , Jejunal Diseases/drug therapy , Male , Middle Aged , Risk Assessment , Tomography, X-Ray Computed/methods , Treatment OutcomeABSTRACT
BACKGROUND: Tracheal diverticula (TD) are rare anomalies that may harbor infected secretions, posing potential risk to patients with lung disease. In an end-stage cystic fibrosis (CF) cohort, we describe the characteristics and associated post-lung transplant (LTx) outcomes of TD. METHODS: Pre-transplant computed tomography (CT)'s were reviewed in CF patients undergoing LTx. TD were characterized radiographically and on autopsy when available. Pre-transplant clinical variables and post-transplant outcomes were compared by TD status. RESULTS: Of 93 patients, 35 (37.6%) had TD. 58% of TD had fat-stranding, and post-mortem TD examinations revealed histology carrying intense submucosal inflammation, and purulent contents that cultured identical species to sputum. There was no difference in post-LTx survival [HR 1.77 (0.82-3.82), p=0.147], bacterial re-colonization, or rejection in patients with TD compared to those without. Patients with TD were more likely to die from infection, but the result was not statistically significant [HR 2.02 (0.62-6.63), p=0.245]. CONCLUSIONS: We found a high prevalence of TD in end-stage CF, where diverticula may represent a large-airway bacterial reservoir. TD were not associated with differences in post-LTx outcomes, but given the infectious concerns further investigation is necessary.
Subject(s)
Cystic Fibrosis , Diverticulum , Tracheal Diseases , Adult , Autopsy/methods , Autopsy/statistics & numerical data , Bacteria/isolation & purification , Cystic Fibrosis/complications , Cystic Fibrosis/mortality , Cystic Fibrosis/physiopathology , Cystic Fibrosis/surgery , Disease Progression , Diverticulum/diagnosis , Diverticulum/epidemiology , Diverticulum/etiology , Diverticulum/microbiology , Female , Humans , Male , Preoperative Care/methods , Prevalence , Sputum/microbiology , Statistics as Topic , Tomography, X-Ray Computed/methods , Tracheal Diseases/diagnosis , Tracheal Diseases/epidemiology , Tracheal Diseases/etiology , Tracheal Diseases/microbiology , United States/epidemiologyABSTRACT
BACKGROUND: Urethral diverticula are rare but underdiagnosed entities that may cause a variety of urinary and pelvic symptoms in women. Management can be very challenging, especially in cases of chronic infection. CASE: A 69-year-old gravida 4, para 2 woman with a history of type 2 diabetes and hypothyroidism presented with long history of a painful midline 3-cm suburethral cystic mass, recurrent urinary tract infections, dysuria, dyspareunia, and incomplete voiding. The diagnosis was consistent with an infected urethral diverticulum unresponsive to multiple courses of oral antibiotics. Given the patient's comorbidities and the persistence of infection of the diverticulum, conservative treatment with urethral dilation was performed before surgical treatment. Urethral dilation successfully alleviated the patient's symptoms; the surgical treatment was not ultimately required, and the patient continues to be completely asymptomatic well over 17 months later. CONCLUSIONS: We present a unique case of infected urethral diverticulum, which was conservatively treated with dilatation and resulted in resolution of all symptoms, and there is no need for further surgical management.
Subject(s)
Amoxicillin-Potassium Clavulanate Combination/therapeutic use , Diverticulum/drug therapy , Escherichia coli Infections/drug therapy , Urethral Diseases/drug therapy , Aged , Dilatation, Pathologic , Diverticulum/microbiology , Escherichia coli/isolation & purification , Escherichia coli Infections/microbiology , Female , Humans , Urethral Diseases/microbiology , Urinary Tract Infections/therapy , Urine/microbiologyABSTRACT
AIM: To provide further insight into the characterization of mucosa-associated Escherichia coli (E. coli) isolated from the colonic mucosa of cancer patients. METHODS: Phylogroups and the presence of cyclomodulin-encoding genes of mucosa-associated E. coli from colon cancer and diverticulosis specimens were determined by PCR. Adhesion and invasion experiments were performed with I-407 intestinal epithelial cells using gentamicin protection assay. Carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) expression in T84 intestinal epithelial cells was measured by enzyme-linked immunosorbent assay and by Western Blot. Gut colonization, inflammation and pro-carcinogenic potential were assessed in a chronic infection model using CEABAC10 transgenic mice. Cell proliferation was analyzed by real-time mRNA quantification of PCNA and immunohistochemistry staining of Ki67. RESULTS: Analysis of mucosa-associated E. coli from colon cancer and diverticulosis specimens showed that whatever the origin of the E. coli strains, 86% of cyclomodulin-positive E. coli belonged to B2 phylogroup and most harbored polyketide synthase (pks) island, which encodes colibactin, and/or cytotoxic necrotizing factor (cnf) genes. In vitro assays using I-407 intestinal epithelial cells revealed that mucosa-associated B2 E. coli strains were poorly adherent and invasive. However, mucosa-associated B2 E. coli similarly to Crohn's disease-associated E. coli are able to induce CEACAM6 expression in T84 intestinal epithelial cells. In addition, in vivo experiments using a chronic infection model of CEACAM6 expressing mice showed that B2 E. coli strain 11G5 isolated from colon cancer is able to highly persist in the gut, and to induce colon inflammation, epithelial damages and cell proliferation. CONCLUSION: In conclusion, these data bring new insights into the ability of E. coli isolated from patients with colon cancer to establish persistent colonization, exacerbate inflammation and trigger carcinogenesis.
Subject(s)
Cell Proliferation , Colonic Neoplasms/microbiology , Escherichia coli/pathogenicity , Intestinal Mucosa/microbiology , Adult , Aged , Aged, 80 and over , Animals , Antigens, CD/metabolism , Biofilms , Cell Adhesion Molecules/genetics , Cell Adhesion Molecules/metabolism , Diverticulum/microbiology , Female , GPI-Linked Proteins/metabolism , Humans , Inflammation , Ki-67 Antigen/metabolism , Male , Mice , Mice, Transgenic , Middle Aged , Polymerase Chain Reaction , Proliferating Cell Nuclear Antigen/metabolismABSTRACT
The differential diagnosis for intense hypermetabolic mediastinal lesions on positron emission tomography (PET) could benefit from the combined morphological and metabolic information present in a fluorodeoxyglucose (FDG) PET/CT study. We report a case of an infected tracheal diverticulum mimicking an FDG-avid malignancy in a patient with a history of chronic lymphoproliferative disease. We review the literature for a systematic approach in the differential diagnosis of cystic mediastinal lesions. The embryological development of the normal tracheobronchial tree is reviewed, followed by a presentation of various congenital and acquired mediastinal lesions. The characteristic CT findings are described for each lesion and the avidity for FDG on PET is mentioned when references are available. This case emphasises that complicated benign processes should be considered in the differential diagnosis of an FDG-avid mediastinal lesion, even in subgroups of patients with significant risk factors for malignancy.
Subject(s)
Abscess/complications , Diverticulum/diagnostic imaging , Diverticulum/microbiology , Fluorodeoxyglucose F18 , Mediastinal Neoplasms/diagnostic imaging , Multimodal Imaging , Positron-Emission Tomography , Radiopharmaceuticals , Tomography, X-Ray Computed , Tracheal Diseases/diagnostic imaging , Tracheal Diseases/microbiology , Aged , Diagnosis, Differential , Female , HumansSubject(s)
Abscess/diagnosis , Diverticulum/diagnosis , Neck , Tracheal Diseases/diagnosis , Abscess/surgery , Anti-Bacterial Agents/therapeutic use , Diagnosis, Differential , Diverticulum/microbiology , Diverticulum/surgery , Dyspnea/diagnosis , Dyspnea/etiology , Follow-Up Studies , Haemophilus Infections/diagnosis , Haemophilus Infections/drug therapy , Humans , Male , Middle Aged , Rare Diseases , Risk Assessment , Tracheal Diseases/surgery , Treatment OutcomeABSTRACT
Microbes that produce methane gas, methanogens, were identified as Archaea in the 1970s but their possible role in disease is only emerging now, after they were found in the large intestine, mouth, and vagina. Significant associations were observed, for instance, between levels of methanogens in periodontal pockets and severity of periodontitis, and between quantities of methanogens in the large intestine and diseases such as colon cancer and diverticulosis. Recently, a role for intestinal methanogens in obesity was proposed. The lesson learned is that for methanogens we have to look at their pathogenicity from a different angle in comparison to classic pathogens that invade tissues and release toxins. This type of pathogenicity has not yet been described for methanogens. Instead, methanogens seem to participate in pathogenicity indirectly, favoring the growth of other microbes, which are directly involved in pathogenesis. This indirect role should not be minimized. On the contrary, it has become clear that a fundamental change of approach to the understanding and control of microbial diseases must be implemented. A comprehensive strategy is needed to elucidate the syntrophic associations that are essential for a healthy relation among microbes (including methanogens) and between them and the host organism, and to unveil those associations that lead to disease.
Subject(s)
Archaea/isolation & purification , Archaea/physiology , Methane/metabolism , Animals , Archaea/metabolism , Colonic Neoplasms/microbiology , Diverticulum/microbiology , Female , Humans , Intestine, Large/microbiology , Male , Mouth/microbiology , Obesity/microbiology , Periodontitis/microbiology , Vagina/microbiologyABSTRACT
Congenital anterior urethral diverticula in adult males are infrequent urological diseases. Clinical manifestation is frequently described with irritative and/or obstructive voiding symptoms or ventral bulging, but manifestation as a scrotal mass is extremely rare. Diagnostic imaging is useful to correctly diagnose the above in the majority of cases. We report the first case of a urethral diverticulum in which neither clinical nor instrumental evaluations were performed to confirm the diagnosis of urethral diverticulum. We stress the importance of a surgical approach in evaluating scrotal mass if diagnostic imaging cannot confirm an exact diagnosis. A complete review of the literature was also carried out.
Subject(s)
Diverticulum/microbiology , Genital Diseases, Male/microbiology , Scrotum/microbiology , Urethral Diseases/microbiology , Diverticulum/surgery , Humans , Male , Middle Aged , Scrotum/surgery , Urethral Diseases/surgerySubject(s)
Bacteria/growth & development , Diverticulum/complications , Intestinal Diseases/complications , Intestine, Small/microbiology , Bacteria/isolation & purification , Diagnosis, Differential , Diverticulum/diagnosis , Diverticulum/microbiology , Female , Humans , Intestinal Diseases/diagnosis , Intestinal Diseases/microbiology , Intestine, Small/diagnostic imaging , Intestine, Small/pathology , Middle Aged , RadiographyABSTRACT
Diverticulosis of the jejunum is a rare finding (0.06 to 1.3%). Possible complications are bacterial overgrowth, malabsorption, bleeding, mechanical obstruction, volvulus and perforation. At present only one case report on familial jejunal diverticulosis has been published. We describe three patients with jejunal diverticulosis within one family, which might suggest inheritance.
Subject(s)
Diverticulum/genetics , Enteritis/genetics , Jejunal Diseases/genetics , Colonic Neoplasms/genetics , Diverticulum/microbiology , Enteritis/microbiology , Female , Humans , Jejunal Diseases/microbiology , Jejunum/microbiology , Jejunum/pathology , Male , Middle Aged , Pedigree , ProbabilitySubject(s)
Diverticulum/microbiology , Duodenal Diseases/microbiology , Duodenal Ulcer/microbiology , Helicobacter Infections/drug therapy , Helicobacter pylori , Peptic Ulcer Hemorrhage/prevention & control , Aged , Amoxicillin/therapeutic use , Anti-Bacterial Agents/therapeutic use , Anti-Ulcer Agents/therapeutic use , Clarithromycin/therapeutic use , Diverticulum/drug therapy , Drug Therapy, Combination/therapeutic use , Duodenal Diseases/drug therapy , Duodenal Ulcer/drug therapy , Female , Follow-Up Studies , Humans , Omeprazole/therapeutic use , Penicillins/therapeutic use , Peptic Ulcer Hemorrhage/microbiologySubject(s)
Diverticulum/microbiology , Jejunal Diseases/microbiology , Aged , Aged, 80 and over , Humans , MaleABSTRACT
OBJECTIVE: To identify features of guttural pouch (auditory tube diverticulum) empyema in horses and compare findings of uncomplicated guttural pouch empyema with guttural pouch empyema complicated by chondroids. DESIGN: Retrospective study. ANIMALS: 91 horses with guttural pouch empyema. PROCEDURE: Medical records of horses with guttural pouch empyema were reviewed. RESULTS: The most common owner complaint and abnormal finding was persistent nasal discharge. Chondroids were detected in 21% (19/91) of affected horses. Streptococcus equi was isolated from the guttural pouch in 14 of 44 horses; for Streptococcus spp, in vitro resistance to sulfadimethoxine and trimethoprim-sulfamethoxazole was detected. Retropharyngeal swelling and pharyngeal narrowing were significantly more prevalent in horses with chondroids, compared with horses with uncomplicated empyema. Ninety-three percent of affected horses were discharged from the hospital; at time of discharge, 66% had complete resolution of disease, 19% had improvement without resolution, and 15% did not have improvement. CONCLUSIONS AND CLINICAL RELEVANCE: Horses with persistent nasal discharge should be examined endoscopically for guttural pouch empyema. Treatment with lavage offers a good prognosis for resolution of uncomplicated guttural pouch empyema. Aggressive treatment with lavage and endoscopic snare removal of chondroids offers a good prognosis and may make surgical intervention unnecessary.
Subject(s)
Diverticulum/veterinary , Empyema/veterinary , Eustachian Tube/pathology , Horse Diseases/pathology , Streptococcus/isolation & purification , Animals , Diverticulum/microbiology , Diverticulum/pathology , Empyema/microbiology , Empyema/pathology , Empyema/therapy , Eustachian Tube/microbiology , Female , Horse Diseases/microbiology , Horse Diseases/therapy , Horses , Male , Microbial Sensitivity Tests/veterinary , Prognosis , Retrospective Studies , Streptococcus/drug effects , Therapeutic Irrigation/veterinaryABSTRACT
Fecal specimens from 10 colorectal cancer, 1 duodenum diverticulosis and 2 healthy adults were examined. Nine fecal enrichments contained Methanobrevibacter. The percentage of methanogen positive individuals was 69% Methanobrevibacter were isolated from fecal enrichments of 4 colorectal cancer and 1 duodenum diverticulosis. The percentage of breath methane positive individuals and methane production had significantly increased in colorectal cancer patients. It will be hopeful that methane production in breath samples at the end of exhalation will became a rapid, simple and non-penetrative method for monitoring precancerous colonic or rectal carcinogenesis and monitoring the relapse of individuals with carcinosectomy.
Subject(s)
Colorectal Neoplasms/microbiology , Feces/chemistry , Methanobacteriaceae/isolation & purification , Breath Tests , Colorectal Neoplasms/metabolism , Diverticulum/metabolism , Diverticulum/microbiology , Duodenal Diseases/metabolism , Duodenal Diseases/microbiology , Methane/analysisABSTRACT
A patient with hepatic histological features of steatohepatitis in association with small bowel diverticulosis and bacterial overgrowth is described. A similar histological picture in the liver is well recognised in association with bacterial overgrowth in excluded loops of small intestine. Jejunal diverticulosis should be considered as a correlate of para-alcoholic hepatitis.
Subject(s)
Diverticulum/microbiology , Fatty Liver, Alcoholic/pathology , Hepatitis, Alcoholic/pathology , Jejunal Diseases/microbiology , Aged , Bacteria/growth & development , Diverticulum, Colon/microbiology , Fatty Liver, Alcoholic/microbiology , Female , Hepatitis, Alcoholic/microbiology , HumansABSTRACT
A case is reported of a patient with symptomatic bacterial overgrowth and Vitamin B12 malabsorption secondary to two duodenal diverticula, treated successfully by surgical excision of the diverticula.
Subject(s)
Diverticulum/surgery , Duodenal Diseases/surgery , Diverticulum/complications , Diverticulum/microbiology , Duodenal Diseases/complications , Duodenal Diseases/microbiology , Female , Humans , Malabsorption Syndromes/etiology , Middle Aged , Vitamin B 12/bloodABSTRACT
Small-intestinal bacterial overgrowth may be one etiologic factor in pigment gallstone disease, previously shown to be prevalent in patients with juxtapapillary duodenal diverticula. In this study the bacterial microflora in the duodenum was examined in 52 patients admitted for endoscopic retrograde cholangiography, 27 with and 25 without duodenal diverticula. Endoscopic sampling was done with a microbiology specimen brush. The reproducibility of the method was good. Presence of gas in the anaerobic cultivation media corresponded closely to growth of Enterobacteriaceae, with a sensitivity of 90% and a specificity of 98%. Gas production in thioglycollate medium with 1% glucose is proposed as a simple criterion of bacterial overgrowth. Patients with diverticula had significantly higher total numbers of bacteria in the duodenum than patients without diverticula (p less than 0.01). Enterobacteriaceae and fecal streptococci dominated the flora in patients with diverticula, and gram-positive cocci were most frequently isolated from patients without diverticula.